In a recent podcast, a Taussig Cancer Center physician discusses treatment options, trials, and more for managing metastatic castrate-resistant prostate cancer.
Understanding the Role of Re-irradiation
Cleveland Clinic radiation oncologists examine re-irradiation for a range of solid tumors
PSMA PET Scan Improves Treatment for Patients With Prostate Cancer
The PSMA PET scan was named a top medical innovation by Cleveland Clinic in 2022. Physicians discuss this promising new imaging approach and its role in earlier detection of prostate cancer.
Two Clinical Trials Evaluate Imaging Agent to Detect Prostate Cancer
When used with positron emission tomography, the agent rhPSMA-7.3 (18F) tags prostate-specific membrane antigen, a protein on the surface of the cancer cells, and identifies it on the scan.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy